Table 1.
Comparison of published test characteristics for POC Chlamydia tests in women.
| Test | Author (year) | Number | Prevalence (% positive) |
Reference standard | Sensitivity % |
Specificity % |
|---|---|---|---|---|---|---|
|
BioStar® OIA® CHLAYMDIA test |
Pate, et al. (1998) | 306 | 13.7% | Culture DFA, PCR | 73.8 | 100 |
| Bandea, et al (2009) |
261 | Not stated | Two NAAT Assays Culture |
59.4 78.6 |
98.4 97.2 |
|
|
Clearview® Chlamydia |
Stratton, et al (1991) |
648 | 6.2% | Culture | 95 | 98 |
| Skulnick, et al (1991) |
965 | 4.5% | Culture | 79 | 99.6 | |
| Yin, et al. (2006) | 1497 | 13.2% | NAAT (PCR) cervical swabs vaginal swabs |
49.7 32.8 |
97.9 99.2 |
|
| QuickVue® | Steingrimsson, et al. (1997) |
724 | 11% | Culture or culture plus DFA |
92% | 99.1 |
| Rani, et al (2002) | 100 | 16% | NAAT | 65 | 100 | |
| 100 | 4% | NAAT | 25 | 100 | ||
|
Chlamydia Rapid Test (CRT) |
Mahilum-Tapay, et al. (2007) |
686 | 8.1% | NAAT | 83.5 | 98.9 |